{"id":67993,"date":"2026-10-27T05:06:35","date_gmt":"2026-10-26T23:36:35","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67993"},"modified":"2026-10-27T05:06:39","modified_gmt":"2026-10-26T23:36:39","slug":"new-series-of-interactive-cardiology-mcqs-15","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 15"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<!-- Cardiology MCQs Part 15 (Full 25 Questions) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: { preflight: false }\n  }\n<\/script>\n\n<div id=\"mcq15-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-rose-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-rose-500 via-fuchsia-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-rose-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-orange-500 via-rose-600 to-fuchsia-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \u2764\ufe0f Advanced Cardiology Series &#8211; Part 15\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-orange-300 via-rose-400 to-pink-400 m-0\">\n      Interactive Cardiology MCQs #15\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-rose-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83c\udfc6<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-rose-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-orange-300 flex items-center gap-1\">\n          <span id=\"mcq15-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq15-progress-bar\" class=\"bg-gradient-to-r from-rose-500 to-orange-400 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-orange-300\"><span id=\"mcq15-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a patient with known rheumatic mitral stenosis (MS), how does the presence of concomitant severe aortic regurgitation (AR) affect the echocardiographic estimation of the Mitral Valve Area (MVA) using the Pressure Half-Time (PHT) method?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"PHT is strongly altered by the rapidly rising left ventricular end-diastolic pressure (LVEDP) caused by severe AR, making the calculation highly inaccurate.\">A. It has no effect; PHT remains the most accurate method for MVA estimation regardless of AR.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe AR causes a rapid rise in LV diastolic pressure, which shortens the PHT, it does not lengthen it.\">B. It artificially lengthens the PHT, leading to an underestimation of the MVA.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Severe AR causes rapid filling of the left ventricle, causing an accelerated rise in LV end-diastolic pressure. This rapidly decreases the transmitral gradient, artificially shortening the PHT and leading to a false overestimation of the MVA (making the MS appear less severe than it is).\">C. It artificially shortens the PHT, leading to an overestimation of the MVA (making MS appear less severe).<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The PHT shortens significantly; it does not become infinite.\">D. It causes the PHT to become infinite, rendering the formula completely incalculable.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which of the following is a recognized mechanism by which Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors provide profound cardiovascular benefits in patients with Heart Failure?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"SGLT2 inhibitors are actually theorized to shift myocardial metabolism toward the highly efficient utilization of ketone bodies, not away from them.\">A. They shift myocardial metabolism entirely toward free fatty acid oxidation and away from ketone bodies.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"They act selectively on the proximal convoluted tubule. Loop diuretics act on the thick ascending limb of the loop of Henle.\">B. They inhibit the Na-K-2Cl symporter in the thick ascending limb of the loop of Henle.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"SGLT2 inhibitors block glucose and sodium reabsorption in the proximal tubule, leading to osmotic diuresis and natriuresis. This decreases plasma volume, reduces cardiac preload and afterload, and improves tubuloglomerular feedback without inappropriately activating the sympathetic nervous system.\">C. They induce osmotic diuresis and natriuresis, reducing both preload and afterload without significant sympathetic activation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"They do not act directly on alpha-1 receptors; they are not alpha-blockers.\">D. They directly block alpha-1 adrenergic receptors in the peripheral vasculature.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 25-year-old male with a structurally normal heart presents with palpitations. The ECG shows a wide-complex tachycardia with a Right Bundle Branch Block (RBBB) morphology and a superior (left) axis. The tachycardia is uniquely terminated by intravenous Verapamil. What is the most likely diagnosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"RVOT VT typically presents with a Left Bundle Branch Block (LBBB) morphology and an inferior axis.\">A. Right Ventricular Outflow Tract (RVOT) Ventricular Tachycardia<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Idiopathic left ventricular fascicular VT (Belhassen VT) most commonly originates from the left posterior fascicle. It classically presents with an RBBB morphology and left axis deviation. It is classically termed 'verapamil-sensitive VT'.\">B. Idiopathic Left Posterior Fascicular Ventricular Tachycardia<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While AVNRT with aberrancy could present as RBBB and terminate with verapamil, the specific combination of RBBB, superior axis, and verapamil sensitivity in a young male strongly points to Belhassen VT.\">C. Atrioventricular Nodal Reentrant Tachycardia (AVNRT) with aberrancy<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Antidromic AVRT involves anterograde conduction down an accessory pathway. Verapamil can be dangerous as it blocks the AV node, potentially increasing conduction down the pathway during AFib.\">D. Antidromic Atrioventricular Reentrant Tachycardia (AVRT) via a left-sided accessory pathway<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When differentiating constrictive pericarditis from restrictive cardiomyopathy using Cardiac Magnetic Resonance (CMR) imaging, which finding is highly specific for constrictive pericarditis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Diffuse subendocardial LGE is a hallmark of cardiac amyloidosis (a form of restrictive cardiomyopathy).\">A. Diffuse subendocardial late gadolinium enhancement (LGE) of the left ventricle<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"CMR in constrictive pericarditis typically shows a thickened pericardium (&gt; 4 mm) and often demonstrates pericardial Late Gadolinium Enhancement (LGE), indicating ongoing pericardial inflammation or fibrosis, which definitively distinguishes it from restrictive cardiomyopathy.\">B. Increased pericardial thickness (&gt; 4 mm) often with pericardial late gadolinium enhancement (LGE)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Biatrial enlargement is common to both conditions due to elevated diastolic filling pressures, and a normal pericardium favors restrictive cardiomyopathy.\">C. Severe biatrial enlargement with a completely normal pericardium<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A profound reduction in myocardial T2* relaxation time is the hallmark of cardiac iron overload (hemochromatosis), a restrictive cardiomyopathy.\">D. Profound reduction in myocardial T2* relaxation time<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In adult congenital heart disease (ACHD), patients who have undergone a Fontan palliation for a single ventricle physiology are at high risk for a specific long-term complication characterized by profound hypoalbuminemia, edema, and immunodeficiency. What is this complication?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Eisenmenger syndrome involves the reversal of a left-to-right shunt due to severe pulmonary hypertension. Fontan patients are already surgically palliated and this does not describe the specific protein-loss syndrome.\">A. Eisenmenger Syndrome<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Protein-Losing Enteropathy (PLE) is a severe complication of the Fontan circulation, driven by chronically elevated systemic venous pressures that cause lymphatic congestion and leakage of serum proteins (albumin, immunoglobulins) into the gut.\">B. Protein-Losing Enteropathy (PLE)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"HCC can occur due to cardiac cirrhosis (Fontan-associated liver disease), but it does not acutely cause the classic triad of profound hypoalbuminemia, generalized edema, and immunodeficiency seen in PLE.\">C. Primary Hepatocellular Carcinoma<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Plastic bronchitis is another known Fontan complication, but it is characterized by the formation of gelatinous casts in the airways, resulting in respiratory distress, not primarily profound hypoalbuminemia.\">D. Plastic Bronchitis<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During Percutaneous Coronary Intervention (PCI), what is the primary clinical indication for using Rotational Atherectomy (e.g., Rotablator)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Thrombus is an absolute contraindication for rotational atherectomy due to the extremely high risk of massive distal embolization and 'no-reflow'. Aspiration thrombectomy is preferred here.\">A. To extract a large, fresh, red thrombus in a patient presenting with an acute STEMI.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Rotational atherectomy uses a high-speed, diamond-tipped burr to drill through heavily calcified, unyielding plaques (lesion modification) that cannot be crossed or adequately expanded by conventional balloons, allowing for subsequent stent delivery.\">B. To modify heavily calcified, undilatable fibrotic lesions to allow for subsequent balloon expansion and stent delivery.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Covered stents (PTFE) are used to seal perforations. Drilling would catastrophicly worsen a perforation.\">C. To seal a Type III coronary artery perforation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Atherectomy is rarely used and often contraindicated in saphenous vein grafts due to the high risk of distal embolization of friable, degenerative graft material.\">D. To treat in-stent restenosis in an older saphenous vein graft.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient undergoes a right heart catheterization for unexplained dyspnea. Oximetry run demonstrates the following oxygen saturations: SVC = 68%, IVC = 70%, Right Atrium = 70%, Right Ventricle = 84%, Pulmonary Artery = 83%. What is the most likely diagnosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"An ASD would cause the oxygen step-up to occur at the Right Atrium level, not the Right Ventricle.\">A. Atrial Septal Defect (ASD)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"There is a significant 'step-up' in oxygen saturation (&gt;= 5-7%) occurring between the Right Atrium (70%) and the Right Ventricle (84%). This indicates mixing of highly oxygenated blood from the left side of the heart directly into the RV, diagnostic of a Ventricular Septal Defect (VSD).\">B. Ventricular Septal Defect (VSD)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A PDA causes a step-up in oxygen saturation at the Pulmonary Artery level, beyond the RV.\">C. Patent Ductus Arteriosus (PDA)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A PFO with a right-to-left shunt would cause systemic desaturation (left-sided hypoxia), not a right-sided oxygen step-up.\">D. Patent Foramen Ovale (PFO) with right-to-left shunting<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          An ECG reveals prominent, positive deflections at the J-point (Osborn waves) most noticeable in the inferior and lateral precordial leads, accompanied by sinus bradycardia and prolongation of the PR, QRS, and QT intervals. Which clinical condition is this pathognomonic for?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypercalcemia classically shortens the QT interval; it does not typically cause Osborn waves.\">A. Severe hypercalcemia<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hyperkalemia causes tall peaked T waves, widening of the QRS, and eventual loss of P waves (sine wave pattern), but not J-point Osborn waves.\">B. Severe hyperkalemia<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Osborn waves (J waves) are positive, dome-like deflections occurring at the junction of the QRS complex and the ST segment. They are highly specific and pathognomonic for severe systemic hypothermia (typically core temp &lt; 32\u00b0C).\">C. Severe systemic hypothermia<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Acute pericarditis causes diffuse ST elevation and PR depression, without specific J-point dome-like waves.\">D. Acute pericarditis<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Inclisiran is a novel lipid-lowering therapy administered subcutaneously twice a year. What is its precise mechanism of action?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes monoclonal antibodies like evolocumab or alirocumab, which target the circulating protein, not the mRNA.\">A. It is a monoclonal antibody that binds directly to circulating PCSK9 proteins.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Inclisiran is a small interfering RNA (siRNA) molecule. It enters hepatocytes and utilizes the intrinsic RNA interference (RNAi) pathway to degrade PCSK9 mRNA, thereby preventing the hepatic synthesis and secretion of the PCSK9 protein entirely.\">B. It is a small interfering RNA (siRNA) that degrades PCSK9 mRNA, preventing the synthesis of PCSK9 in the liver.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes bempedoic acid.\">C. It is an ATP citrate lyase (ACL) inhibitor acting upstream of HMG-CoA reductase.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes ANGPTL3 inhibitors (e.g., evinacumab).\">D. It acts as a direct inhibitor of Angiopoietin-like 3 (ANGPTL3).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to current AHA\/ACC\/HFSA guidelines, which patient with Heart Failure with Reduced Ejection Fraction (HFrEF) on optimal medical therapy has a Class I recommendation for Cardiac Resynchronization Therapy (CRT)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Non-LBBB morphologies (like RBBB) with a QRS &lt; 150 ms have a poor response to CRT and lack a Class I indication.\">A. LVEF 30%, sinus rhythm, Right Bundle Branch Block (RBBB) with a QRS duration of 130 ms.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A Class I recommendation for CRT exists for patients in sinus rhythm with an LVEF &lt;= 35%, a Left Bundle Branch Block (LBBB) morphology, and a QRS duration &gt;= 150 ms, who are suffering from NYHA Class II-IV symptoms despite guideline-directed medical therapy.\">B. LVEF 30%, sinus rhythm, Left Bundle Branch Block (LBBB) with a QRS duration of 160 ms.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"An LVEF of 40% does not meet standard primary criteria for CRT unless the patient has an anticipated requirement for high-burden ventricular pacing.\">C. LVEF 40%, atrial fibrillation, LBBB with a QRS duration of 160 ms.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A narrow QRS (&lt; 130 ms) is a strict contraindication for CRT as it can paradoxically induce dyssynchrony and worsen mortality (proven in the EchoCRT trial).\">D. LVEF 25%, sinus rhythm, normal QRS duration of 100 ms.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In Hypertrophic Obstructive Cardiomyopathy (HOCM), what are the primary physical fluid dynamics principles believed to cause Systolic Anterior Motion (SAM) of the mitral valve?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"SAM is driven primarily by flow drag (the pushing force of the blood catching the elongated anterior mitral leaflet) combined with the Venturi effect (low pressure created by high-velocity flow in the narrowed LVOT pulling the leaflet inward).\">A. A combination of hydrodynamic drag forces acting on an elongated leaflet and the Venturi effect pulling it into the narrowed LVOT.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"SAM occurs during systole when the mitral valve should be closed, not due to retrograde diastolic flow.\">B. Retrograde diastolic flow from severe aortic regurgitation impacting the anterior leaflet.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Papillary muscle rupture causes a flail leaflet and massive acute MR, not dynamic SAM obstruction.\">C. Ischemic rupture of the anterolateral papillary muscle causing leaflet prolapse.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe calcification of the annulus causes structural rigidity (MAC), which actually makes the dynamic movement of SAM less likely to occur.\">D. Severe calcification of the mitral annulus preventing normal systolic closure.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 55-year-old patient undergoing chemotherapy for colorectal cancer with 5-Fluorouracil (5-FU) develops acute, severe chest pain during the infusion. An ECG shows transient ST-segment elevations. What is the most likely mechanism of this specific cardiotoxicity?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the specific mechanism of anthracycline toxicity (e.g., doxorubicin).\">A. Direct, dose-dependent myocardial necrosis and apoptosis (Type I toxicity)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"5-Fluorouracil (and its oral prodrug capecitabine) is notorious for causing profound, often refractory coronary vasospasm, leading to angina, ischemia, and potentially myocardial infarction or lethal arrhythmias during or shortly after infusion.\">B. Severe, acute coronary vasospasm<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the mechanism of Immune Checkpoint Inhibitor (ICI) toxicity.\">C. T-cell mediated autoimmune fulminant myocarditis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is a potential side effect of VEGF inhibitors (like bevacizumab), not 5-FU.\">D. Acute severe hypertension leading to aortic dissection<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Colchicine is a Class I recommendation as an adjunct to NSAIDs for acute idiopathic pericarditis to hasten recovery and prevent recurrence. What is its cellular mechanism of action?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes NSAIDs (ibuprofen, indomethacin, aspirin).\">A. It irreversibly inhibits cyclooxygenase-1 (COX-1) and COX-2 enzymes.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Colchicine binds to tubulin, preventing its polymerization into microtubules. This disrupts the cytoskeleton of neutrophils, severely impairing their motility, degranulation, and chemotaxis into the inflamed pericardium.\">B. It binds to tubulin, inhibiting microtubule polymerization and thereby suppressing neutrophil motility and degranulation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes biologic agents like anakinra (an IL-1 receptor antagonist).\">C. It is a direct antagonist of the Interleukin-1 (IL-1) receptor.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This broadly describes the mechanism of action of corticosteroids.\">D. It directly inhibits the transcription of pro-inflammatory genes in the nucleus.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In typical &#8220;Slow-Fast&#8221; Atrioventricular Nodal Reentrant Tachycardia (AVNRT), how is the RP interval characterized on a surface ECG?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In typical (Slow-Fast) AVNRT, the anterograde limb is the slow pathway and the retrograde limb is the fast pathway. Because retrograde atrial activation happens almost simultaneously with ventricular activation, the P wave is buried in or occurs immediately after the QRS, yielding a very short RP interval (RP &lt; 70 ms).\">A. It is a short-RP tachycardia (RP interval &lt; 70 ms), often with retrograde P waves buried in or just after the QRS complex (pseudo r&#8217; in V1).<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A long RP interval is characteristic of atypical (Fast-Slow) AVNRT, orthodromic AVRT with a slowly conducting pathway, or PJRT.\">B. It is a long-RP tachycardia (RP &gt; PR interval), with P waves clearly visible before the next QRS.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes a state of AV dissociation (e.g., ventricular tachycardia), not AVNRT, which is dependent on both atria and ventricles.\">C. The RP interval is completely variable because there is AV dissociation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Wenckebach periodicity occurs in atrial tachycardias or flutter, but AVNRT is an obligate 1:1 circuit.\">D. The RP interval progressively lengthens until a QRS is dropped.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When considering Transcatheter Aortic Valve Replacement (TAVR) in a patient with a Bicuspid Aortic Valve (BAV), what are the two most significantly elevated procedural risks compared to TAVR in a tricuspid aortic valve?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"TAVR does not inherently cause mitral stenosis; complete heart block is a risk in both, but not the distinguishing anatomical risk for bicuspid valves.\">A. Complete heart block and acute severe mitral stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Bicuspid valves are often heavily and asymmetrically calcified with a more elliptical annulus. This makes circular stent expansion difficult, leading to significantly higher rates of significant paravalvular leak (PVL) and a higher risk of catastrophic aortic root\/annular rupture during balloon dilation.\">B. Significant paravalvular leak and aortic root\/annular rupture<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Coronary obstruction is primarily related to low coronary ostia height, not directly to the bicuspid nature of the valve itself.\">C. Coronary ostial obstruction and ventricular septal defect formation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aortic dissection is a risk, but rapid bioprosthesis degeneration is a long-term durability issue, not an acute procedural one.\">D. Immediate acute type A aortic dissection and rapid bioprosthesis degeneration<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Palpation of the carotid pulse reveals a &#8220;pulsus parvus et tardus.&#8221; This physical finding is classically associated with which valvular abnormality?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"&quot;Pulsus parvus et tardus&quot; translates to a pulse that is weak (parvus) and delayed (tardus). It is the classic carotid pulse finding in severe aortic stenosis, reflecting the severely obstructed left ventricular outflow.\">A. Severe Aortic Stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aortic regurgitation classically presents with a bounding, collapsing &quot;water-hammer&quot; (Corrigan's) pulse.\">B. Severe Aortic Regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitral regurgitation typically features a brisk carotid upstroke because the LV empties rapidly into the low-pressure left atrium.\">C. Severe Mitral Regurgitation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"HOCM presents with a classic &quot;bisferiens&quot; (double-peaked) pulse with a rapid initial upstroke followed by a mid-systolic dip.\">D. Hypertrophic Obstructive Cardiomyopathy<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Following an orthotopic heart transplantation, what is the gold standard diagnostic procedure utilized routinely during the first year to monitor for cellular or antibody-mediated rejection?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While strain echo is useful as an adjunct, it is not the gold standard for definitive tissue diagnosis of rejection.\">A. Serial global longitudinal strain (GLS) echocardiography<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"PET scans are used for assessing viability or inflammation (like sarcoidosis), not routine rejection surveillance.\">B. FDG-PET imaging<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Right ventricular endomyocardial biopsy (EMB), usually performed via the internal jugular vein, remains the gold standard for diagnosing acute cellular and antibody-mediated rejection post-heart transplant.\">C. Right ventricular endomyocardial biopsy<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Troponin levels can be chronically elevated or unreliable in the post-operative period and lack specificity for cellular rejection.\">D. Daily high-sensitivity cardiac troponin assays<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 14-year-old collapses during physical exertion. A subsequent exercise stress test reveals frequent premature ventricular contractions that organize into a polymorphic &#8220;bidirectional&#8221; ventricular tachycardia as the heart rate increases. Which genetic mutation is most commonly responsible for this condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"SCN5A mutations are associated with Brugada syndrome and Long QT Syndrome Type 3.\">A. SCN5A<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"This clinical presentation is classic for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The hallmark is exercise-induced bidirectional VT. The most common genetic cause is a mutation in the RYR2 gene (Ryanodine Receptor 2), which regulates calcium release from the sarcoplasmic reticulum.\">B. RYR2<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"MYBPC3 is the most common sarcomeric mutation causing Hypertrophic Cardiomyopathy (HCM).\">C. MYBPC3<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"PKP2 is the most common desmosomal mutation associated with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC).\">D. PKP2<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the Stanford classification system, how is an acute aortic dissection definitively managed if it involves the ascending aorta (Stanford Type A)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the standard management for uncomplicated Type B dissections (descending aorta).\">A. Strict medical therapy with IV beta-blockers and vasodilators to maintain systolic BP &lt; 120 mmHg.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"A Stanford Type A dissection (involving the ascending aorta) is a catastrophic surgical emergency carrying a mortality rate of 1-2% per hour initially. It requires emergent open surgical repair to prevent cardiac tamponade, coronary occlusion, and fatal aortic rupture.\">B. It is a surgical emergency requiring immediate open surgical repair.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"TEVAR is increasingly used for complicated Type B dissections, but open surgery remains the standard for ascending (Type A) dissections.\">C. Endovascular stenting (TEVAR) is the preferred first-line therapy.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Thrombolytics are absolutely contraindicated in any aortic dissection.\">D. Immediate administration of thrombolytics to dissolve the false lumen clot.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which echocardiographic sign is the most sensitive indicator of early cardiac tamponade physiology?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"RV diastolic collapse is highly specific for clinical tamponade, but it occurs later in the disease process as pressures continue to rise.\">A. Right ventricular early diastolic collapse<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Right atrial systolic collapse (inversion of the RA free wall during atrial diastole\/ventricular systole) is the earliest echocardiographic sign of hemodynamic compromise in a pericardial effusion, making it the most sensitive marker for impending tamponade.\">B. Right atrial systolic collapse (inversion)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"IVC dilation is a sign of elevated right-sided pressures but is not specific to tamponade.\">C. Inferior vena cava plethora without respiratory variation<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"LV collapse indicates extreme, pre-mortem tamponade and is very rare due to the thick LV wall.\">D. Left ventricular diastolic collapse<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient taking the direct oral anticoagulant (DOAC) apixaban presents with life-threatening gastrointestinal bleeding. Which specific reversal agent is FDA-approved to neutralize apixaban?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Idarucizumab is a monoclonal antibody specifically designed to reverse the direct thrombin inhibitor dabigatran, not factor Xa inhibitors.\">A. Idarucizumab<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Andexanet alfa is a recombinant modified human factor Xa decoy protein that binds and sequesters factor Xa inhibitors (like rivaroxaban and apixaban), rapidly reversing their anticoagulant effect.\">B. Andexanet alfa<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Protamine sulfate reverses unfractionated heparin and (partially) low molecular weight heparin.\">C. Protamine sulfate<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Vitamin K reverses warfarin (a vitamin K antagonist), but has no effect on DOACs.\">D. Intravenous Vitamin K1<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 45-year-old female presents with elevated troponins and chest pain. Coronary angiography reveals completely normal, unobstructed coronary arteries (MINOCA). What is the most critical next non-invasive diagnostic test to determine the underlying etiology?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While echo provides functional data and wall motion abnormalities, it cannot definitively differentiate tissue-level pathologies like myocarditis vs. microvascular infarction.\">A. Transthoracic echocardiogram with contrast<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A CT angiogram is redundant since invasive angiography already showed clear arteries.\">B. Coronary CT Angiography (CCTA)<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Cardiac Magnetic Resonance (CMR) imaging is the cornerstone for evaluating MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). It can differentiate between true ischemic injury (subendocardial LGE), myocarditis (epicardial\/midwall LGE), and Takotsubo cardiomyopathy (edema without LGE).\">C. Cardiac Magnetic Resonance (CMR) imaging<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Nuclear stress tests evaluate for obstructive CAD, which has already been ruled out.\">D. Radionuclide myocardial perfusion imaging (SPECT)<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In developed nations, the vast majority of cases of severe Tricuspid Regurgitation (TR) are classified as &#8220;secondary&#8221; (functional). What is the primary pathophysiological driver of secondary TR?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes a primary (organic) cause of TR, specifically carcinoid heart disease.\">A. Carcinoid plaque deposition on the ventricular surface of the tricuspid leaflets.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Secondary (functional) TR is caused by right ventricular dilation or right atrial enlargement (often secondary to left-sided heart disease or pulmonary hypertension). This pulls the annulus apart and tethers the leaflets, preventing coaptation, despite the valve leaflets being structurally normal.\">B. Dilation of the right ventricle and tricuspid annulus, leading to leaflet tethering and malcoaptation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes a primary infectious cause (endocarditis).\">C. Direct destruction of the valve leaflets by Staphylococcus aureus endocarditis.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes rheumatic heart disease, which causes primary TR (and is more common in developing nations).\">D. Rheumatic commissural fusion and leaflet shortening.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Which patient profile is the most established indication for the implantation of a leadless permanent pacemaker (e.g., Micra)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Heart failure requiring CRT needs multi-chamber pacing (RA, RV, LV). Current leadless pacemakers do not yet provide full CRT biventricular pacing routinely.\">A. A patient with severe heart failure and LBBB requiring Cardiac Resynchronization Therapy (CRT).<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Leadless pacemakers are implanted directly into the right ventricle via the femoral vein. They are ideal for patients requiring single-chamber pacing who lack upper extremity venous access, have a history of recurrent device pocket infections, or possess an unacceptably high risk of infection (e.g., on hemodialysis).\">B. A patient with permanent atrial fibrillation and slow ventricular response who has bilateral subclavian vein occlusions or high infection risk.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada requires an Implantable Cardioverter Defibrillator (ICD) to terminate VF. A standard leadless pacemaker cannot deliver defibrillation shocks.\">C. A young patient with Brugada syndrome who requires primary prevention defibrillation.<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Intact AV conduction with sinus node dysfunction requires dual-chamber pacing to preserve AV synchrony. Standard RV leadless pacing would cause pacemaker syndrome.\">D. A patient with isolated sinus node dysfunction and completely intact AV conduction.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Elevated levels of Lipoprotein(a) [Lp(a)] are recognized as a highly prevalent, genetically determined risk factor. In addition to driving atherosclerotic cardiovascular disease (ASCVD), high Lp(a) levels are uniquely and independently linked to the rapid progression of which specific cardiovascular pathology?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Lp(a) acts through both atherothrombotic and inflammatory mechanisms. In addition to causing coronary artery disease, elevated Lp(a) strongly promotes the osteogenic differentiation of valvular interstitial cells, driving the rapid progression of Calcific Aortic Valve Stenosis.\">A. Calcific Aortic Valve Stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Rheumatic mitral stenosis is immunologically mediated post-Streptococcus infection, not lipid-driven.\">B. Rheumatic Mitral Stenosis<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Dilated cardiomyopathy is primarily caused by genetics (e.g., TTN), toxins (alcohol), or myocarditis, not Lp(a).\">C. Non-ischemic Dilated Cardiomyopathy<\/button><button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Myxomatous degeneration is genetic or connective tissue related (e.g., Marfan syndrome), completely independent of lipoproteins.\">D. Myxomatous Mitral Valve Prolapse<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq15Correct = 0;\n  let mcq15Answered = 0;\n  const mcq15Total = 25;\n\n  document.querySelectorAll('#mcq15-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq15Answered++;\n\n        document.getElementById('mcq15-answered-count').innerText = mcq15Answered;\n        const pct = (mcq15Answered \/ mcq15Total) * 100;\n        document.getElementById('mcq15-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq15Correct++;\n          document.getElementById('mcq15-correct-count').innerText = mcq15Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-emerald-950\/80', 'border-emerald-500', 'text-emerald-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-red-950\/80', 'border-red-500', 'text-red-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-emerald-950\/40', 'border-emerald-500\/55', 'text-emerald-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-emerald-400' : 'text-red-400'}\">\n            ${isCorrect ? 'Clinical Explanation' : 'Explanation & Correct Answer'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-emerald-950\/45' : 'bg-red-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-emerald-500\/30' : 'border-red-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\u2764\ufe0f Advanced Cardiology Series &#8211; Part 15 Interactive Cardiology MCQs #15 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In a patient with known rheumatic mitral stenosis (MS), how does the presence of concomitant severe aortic regurgitation (AR) affect the echocardiographic estimation of the Mitral Valve Area [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67995,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-67993","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 15 Interactive Cardiology MCQs #15 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In a patient with known rheumatic mitral stenosis (MS), how does the presence of concomitant severe aortic regurgitation (AR) affect the echocardiographic estimation of the Mitral Valve Area [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-26T23:36:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-26T23:36:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 15\",\"datePublished\":\"2026-10-26T23:36:35+00:00\",\"dateModified\":\"2026-10-26T23:36:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/\"},\"wordCount\":1671,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg\",\"datePublished\":\"2026-10-26T23:36:35+00:00\",\"dateModified\":\"2026-10-26T23:36:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-15\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 15\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders","og_description":"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 15 Interactive Cardiology MCQs #15 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 In a patient with known rheumatic mitral stenosis (MS), how does the presence of concomitant severe aortic regurgitation (AR) affect the echocardiographic estimation of the Mitral Valve Area [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-26T23:36:35+00:00","article_modified_time":"2026-10-26T23:36:39+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 15","datePublished":"2026-10-26T23:36:35+00:00","dateModified":"2026-10-26T23:36:39+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/"},"wordCount":1671,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/","name":"New Series of Interactive Cardiology MCQs 15 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg","datePublished":"2026-10-26T23:36:35+00:00","dateModified":"2026-10-26T23:36:39+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-15.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-15\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 15"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67993"}],"version-history":[{"count":1,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67993\/revisions"}],"predecessor-version":[{"id":67994,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67993\/revisions\/67994"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67995"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}